 |
인쇄하기
취소
|
Hanmi sales increased 10% in 2008
Hanmi Pharm’s sales increased 10 percent last year as the company saw 11 products exceed 10 billion won.
Those involved are Amordipin, antihypertensive agent (57 billion won); Medilac, preparations for intestinal flora (18 billion won);
Slimmer, anti-obesity agent (16 billion won); Clari, antibiotic (16 billion won); Triaxone, antibiotic (13 billion won); Canitil, anti-dementia drug (13 bi...
Those involved are Amordipin, antihypertensive agent (57 billion won); Medilac, preparations for intestinal flora (18 billion won);
Slimmer, anti-obesity agent (16 billion won); Clari, antibiotic (16 billion won); Triaxone, antibiotic (13 billion won); Canitil, anti-dementia drug (13 bi...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.